Johnson & Johnson (NYSE:JNJ) subsidiary DePuy is close to settling the majority of consumers lawsuits against it related to the alleged defectiveness of its Pinnacle metal-on-metal hips, according to a Bloomberg report.
A federal jury in Dallas that was hearing testimony in damage claims brought by Pinnacle recipients was dismissed upon news of the settlement deal, according to the report.
“The parties have reached an agreement that hopefully will resolve most, if not all, of the litigation,” attorney Mark Lanier, who leads one of the consolidated 10,000-suit litigations against J&J, said, according to Blloomberg.
The company has not yet officially commented on the case, and may not speak on the matter in the future, DePuy spokesperson Mindy Tinsely said, according to the report.
The settlement comes only weeks after J&J’s DePuy reached a $120 million settlement deal with 46 U.S. Attorneys General in a case alleging that the company illegally promoted its Pinnacle Ultamet and ASR XL metal-on-metal hip implants.
Last December, another Bloomberg report suggested that J&J was willing to put more than $400 million on the table to settle consumer allegations that its Pinnacle line of metal-on-metal hips were defective and caused problems including metal poisoning.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.